A gene that significantly influences the survival rate of people with MND by 14 months has been discovered by an international collaboration of researchers - funded in part by the Association.
Research carried out by American scientists who have generated ‘patient-specific’ stem cells from people living with MND holds great promise for advancing MND research.
A newly identified cause of the rare inherited form of MND could open up a new avenue of investigation into the mechanisms underlying all forms of the disease, with the potential to dramatically advance research.
Clinical trial using the drug ONO-2506PO has been halted by a pharmaceutical company after failing to show that it is effective in treating motor neurone disease.
THE ALS Association in the USA, along with the collaboration of the ALS Society of Canada, have announced that they are funding a major lithium clinical trial.
American scientists have successfully created cloned monkey stem cells, reinforcing hopes that scientists will eventually be able to use human stem cells for MND research.
On 26 September 2006 CytRx Corporation announced that their drug Arimoclomol had been shown to be safe and well tolerated in a clinical trial of people with MND.
A company called Esperanza has sent out details of its treatment for MND, the beneficial effects of which are unproven. This article explains what we know about this treatment.
There is some evidence that occupational exposure to extremely low magnetic fields (EMFs) may be linked to MND. This was a storyline in a recent television drama.
Research